| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| ALKSAlkermes plc | 4.98B | 30.10 | 21.05 | -5.25% | 16.37% | 13.28% | 0.01% | 0.04 |
| ADMAADMA Biologics, Inc. | 3.71B | 15.57 | 19.22 | 65.15% | 42.87% | 48.57% | 2.97% | 0.24 |
| UTHRUnited Therapeutics Corporation | 21.99B | 503.90 | 18.09 | 10.61% | 41.94% | 18.81% | 4.73% | |
| PCSAProcessa Pharmaceuticals, Inc. | 114.71M | 2.17 | -0.56 | -221.71% | 0.04 | |||
| UNCYUnicycive Therapeutics, Inc. | 144.49M | 6.93 | -1.24 | -100% | -89.15% | 0.10 | ||
| PTHSPelthos Therapeutics Inc. | 85.29M | 26.36 | -1.95 | -318.41% | -40.48% | |||
| MISTMilestone Pharmaceuticals Inc. | 145.64M | 1.71 | -2.55 | -100% | -282.97% | 4.17 | ||
| AMRNAmarin Corporation plc | 5.74B | 13.80 | -3.45 | -25.51% | -38.01% | -18.78% | 0.02 |
Analyze head-to-head performance against top industry competitors across valuation, growth, and profitability metrics.
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 42.13M | 48.65M | 15.39M | 60.37M | 73.41M | 71.86M | 55.31M | 51.35M | 57.42M | 64.38M |
| Revenue Growth % | 260.42% | 15.48% | -68.37% | 292.37% | 21.61% | -2.12% | -23.03% | -7.17% | 11.84% | 12.12% |
| Cost of Goods Sold | 4.66M | 2.89M | 6.03M | 715K | 0 | 0 | 193.66M | 63.39M | 40.62M | 0 |
| COGS % of Revenue | 11.05% | 5.95% | 39.19% | 1.18% | - | - | 350.12% | 123.46% | 70.74% | - |
| Gross Profit | 37.47M | 45.75M | 9.36M | 59.66M | 73.41M | 71.86M | -138.35M | -12.05M | 16.8M | 64.38M |
| Gross Margin % | 88.95% | 94.05% | 60.81% | 98.82% | 100% | 100% | -250.12% | -23.46% | 29.26% | 100% |
| Gross Profit Growth % | 391.07% | 22.11% | -79.55% | 537.61% | 23.06% | -2.12% | -292.53% | 91.29% | 239.49% | 283.15% |
| Operating Expenses | 219.37M | 226.22M | 269.48M | 298.41M | 325.33M | 369.48M | 119.44M | 79.91M | 72.84M | 111.33M |
| OpEx % of Revenue | 520.74% | 465.02% | 1751.46% | 494.3% | 443.14% | 514.19% | 215.94% | 155.63% | 126.84% | 172.92% |
| Selling, General & Admin | 90.2M | 84.51M | 95.59M | 97.06M | 106.08M | 108.53M | 0 | 67.07M | 70.45M | 69.17M |
| SG&A % of Revenue | 214.13% | 173.72% | 621.29% | 160.77% | 144.5% | 151.04% | - | 130.63% | 122.69% | 107.44% |
| Research & Development | 129.16M | 141.71M | 173.89M | 201.35M | 219.25M | 260.95M | 201.55M | 70.07M | 46.34M | 37.64M |
| R&D % of Revenue | 306.62% | 291.3% | 1130.16% | 333.52% | 298.65% | 363.16% | 364.39% | 136.47% | 80.7% | 58.47% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | -82.11M | -57.24M | -43.96M | 4.51M |
| Operating Income | -181.9M | -180.47M | -260.12M | -238.75M | -251.91M | -297.63M | -257.78M | -91.96M | -56.03M | -46.95M |
| Operating Margin % | -431.8% | -370.96% | -1690.65% | -395.48% | -343.14% | -414.19% | -466.06% | -179.09% | -97.58% | -72.92% |
| Operating Income Growth % | 21.78% | 0.79% | -44.14% | 8.22% | -5.51% | -18.15% | 13.39% | 64.33% | 39.06% | 16.21% |
| EBITDA | -178.91M | -177.35M | -256.1M | -235.59M | -245.7M | -290.65M | -252.97M | -88.92M | -54.03M | -43.33M |
| EBITDA Margin % | -424.7% | -364.55% | -1664.47% | -390.24% | -334.68% | -404.49% | -457.36% | -173.18% | -94.1% | -67.31% |
| EBITDA Growth % | 22.17% | 0.87% | -44.4% | 8.01% | -4.29% | -18.3% | 12.96% | 64.85% | 39.23% | 19.8% |
| D&A (Non-Cash Add-back) | 2.99M | 3.12M | 4.03M | 3.17M | 6.21M | 6.97M | 4.81M | 3.04M | 2M | 3.62M |
| EBIT | -181.27M | -179.16M | -263.16M | -215.6M | -209.81M | -294.8M | -237.64M | -79.12M | -53.65M | -42.07M |
| Net Interest Income | 631K | -92K | -3.76M | 1.48M | -23.47M | -4.11M | -7.44M | 2.18M | 6.77M | 2.33M |
| Interest Income | 631K | 1.31M | 4.79M | 11.97M | 8.39M | 4.44M | 1.11M | 8.54M | 9.12M | 4.88M |
| Interest Expense | 0 | 1.4M | 8.55M | 10.48M | 31.86M | 8.55M | 8.55M | 6.37M | 2.35M | 2.55M |
| Other Income/Expense | 631K | -92K | -11.59M | 12.67M | 10.24M | -5.72M | -7.44M | -858K | 6.77M | 2.33M |
| Pretax Income | -181.27M | -180.56M | -271.71M | -226.09M | -241.68M | -303.34M | -265.22M | -92.81M | -49.27M | -44.61M |
| Pretax Margin % | -430.3% | -371.15% | -1765.96% | -374.5% | -329.2% | -422.15% | -479.51% | -180.76% | -85.8% | -69.3% |
| Income Tax | 951K | 10.11M | 13.69M | -10.56M | -5.22M | -8.52M | -151K | 9K | 5.92M | 11.8M |
| Effective Tax Rate % | 100.52% | 105.6% | 105.04% | 95.33% | 97.84% | 91.65% | 75.19% | -939.65% | 112.02% | 126.46% |
| Net Income | -182.22M | -190.67M | -285.4M | -215.52M | -236.46M | -278.02M | -199.43M | 872.13M | -55.19M | -56.42M |
| Net Margin % | -432.56% | -391.94% | -1854.97% | -357.01% | -322.08% | -386.9% | -360.55% | 1698.54% | -96.11% | -87.63% |
| Net Income Growth % | 23.13% | -4.64% | -49.69% | 24.48% | -9.71% | -17.58% | 28.27% | 537.32% | -106.33% | -2.22% |
| Net Income (Continuing) | -182.22M | -190.67M | -285.4M | -215.52M | -236.46M | -294.82M | -265.07M | -92.82M | -55.19M | -56.42M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 16.81M | 65.64M | 964.96M | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -5.34 | -4.26 | -5.45 | -3.99 | -4.25 | -4.46 | -2.87 | -1.26 | -1.00 | -1.15 |
| EPS Growth % | 28.42% | 20.22% | -27.93% | 26.79% | -6.52% | -4.94% | 35.65% | 56.1% | 20.63% | -15% |
| EPS (Basic) | -5.34 | -4.26 | -5.45 | -3.99 | -4.25 | -4.46 | -2.87 | -1.26 | -1.00 | -1.15 |
| Diluted Shares Outstanding | 34.15M | 44.71M | 52.35M | 53.97M | 55.61M | 62.34M | 69.46M | 73.59M | 55.3M | 48.85M |
| Basic Shares Outstanding | 34.15M | 44.71M | 52.35M | 53.97M | 55.61M | 62.34M | 69.46M | 73.59M | 55.3M | 48.85M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 237.47M | 528.5M | 378.75M | 532.82M | 338.49M | 393.34M | 249.87M | 353.46M | 133.54M | 161.07M |
| Cash & Short-Term Investments | 172.43M | 501.1M | 348.57M | 505.28M | 280.83M | 292.94M | 173.47M | 327.48M | 102.43M | 88.35M |
| Cash Only | 112.71M | 344.71M | 88.98M | 378.02M | 58.06M | 81.47M | 89.96M | 298.17M | 39.55M | 37.8M |
| Short-Term Investments | 59.73M | 156.39M | 259.59M | 127.25M | 222.77M | 211.47M | 83.51M | 29.31M | 62.88M | 50.55M |
| Accounts Receivable | 37.15M | 9.72M | 9.36M | 10.67M | 50.57M | 69.67M | 57.6M | 16.79M | 17.47M | 68.44M |
| Days Sales Outstanding | 321.92 | 72.94 | 222.09 | 64.53 | 251.42 | 353.88 | 380.1 | 119.32 | 111.07 | 388.01 |
| Inventory | 10.01M | 12.22M | 16.83M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 784.16 | 1.54K | 1.02K | - | - | - | - | - | - | - |
| Other Current Assets | 5.12M | 2.4M | 3.7M | 0 | 7.09M | 10.36M | 8.56M | 7.68M | 11.6M | 4.2M |
| Total Non-Current Assets | 62.64M | 110.75M | 62.65M | 27.41M | 70.34M | 75.72M | 124.95M | 253.94M | 248.46M | 193.09M |
| Property, Plant & Equipment | 9.87M | 8.46M | 10.16M | 13.18M | 59.25M | 59.68M | 53.35M | 52M | 45.35M | 35.77M |
| Fixed Asset Turnover | 4.27x | 5.75x | 1.51x | 4.58x | 1.24x | 1.20x | 1.04x | 0.99x | 1.27x | 1.80x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 50.86M | 91.56M | 41.59M | 11.87M | 9.5M | 833K | 68.37M | 0 | 0 | 0 |
| Other Non-Current Assets | 1.91M | 10.73M | 10.91M | 2.37M | 1.59M | 15.2M | 3.23M | 201.94M | 203.1M | 157.32M |
| Total Assets | 300.12M | 639.25M | 441.4M | 560.24M | 408.83M | 469.06M | 374.82M | 607.4M | 382M | 354.16M |
| Asset Turnover | 0.14x | 0.08x | 0.03x | 0.11x | 0.18x | 0.15x | 0.15x | 0.08x | 0.15x | 0.18x |
| Asset Growth % | -11.15% | 113% | -30.95% | 26.92% | -27.03% | 14.73% | -20.09% | 62.05% | -37.11% | -7.29% |
| Total Current Liabilities | 49.47M | 49.27M | 62.55M | 98.55M | 111.7M | 123.57M | 58.59M | 28.71M | 24.77M | 32.09M |
| Accounts Payable | 18.8M | 1.73M | 5.92M | 9.03M | 4.76M | 6.78M | 3.1M | 1.55M | 1.52M | 2.24M |
| Days Payables Outstanding | 1.47K | 218.57 | 358.58 | 4.61K | - | - | 5.84 | 8.95 | 13.69 | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 17.61M | 29.2M | 17.44M | 0 | 0 | 0 |
| Deferred Revenue (Current) | 144K | 152K | 125K | 43.4M | 31.57M | 11.52M | 98K | 24K | 0 | 0 |
| Other Current Liabilities | 19.66M | 33.36M | 32.37M | 22.32M | 29.58M | 40.83M | 25.15M | -24K | 12.88M | 0 |
| Current Ratio | 4.80x | 10.73x | 6.05x | 5.41x | 3.03x | 3.18x | 4.26x | 12.31x | 5.39x | 5.02x |
| Quick Ratio | 4.60x | 10.48x | 5.79x | 5.41x | 3.03x | 3.18x | 4.26x | 12.31x | 5.39x | 5.02x |
| Cash Conversion Cycle | -367.72 | 1.4K | 882.24 | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 7.58M | 239.75M | 263.67M | 513.27M | 520.96M | 649.24M | 654.8M | 136.88M | 144.24M | 146.53M |
| Long-Term Debt | 0 | 222.68M | 223.75M | 454.35M | 445.19M | 599.84M | 599.39M | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 47.73M | 47.22M | 52.68M | 45.41M | 45.24M | 39.11M |
| Deferred Tax Liabilities | 0 | 0 | 0 | -26.18M | 0 | 0 | 240K | 0 | 0 | 0 |
| Other Non-Current Liabilities | 7.58M | 17.08M | 39.92M | 32.74M | 21.29M | 1.83M | 2.18M | 91.29M | 99M | 107.42M |
| Total Liabilities | 57.05M | 289.02M | 326.22M | 611.82M | 632.67M | 772.81M | 713.39M | 165.6M | 169M | 178.62M |
| Total Debt | 0 | 222.68M | 223.75M | 454.35M | 510.53M | 676.26M | 669.52M | 52.16M | 49.16M | 49.82M |
| Net Debt | -112.71M | -122.03M | 134.77M | 76.33M | 452.46M | 594.79M | 579.56M | -246.01M | 9.61M | 12.02M |
| Debt / Equity | - | 0.64x | 1.94x | - | - | - | - | 0.12x | 0.23x | 0.28x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | -128.54x | -30.43x | -22.78x | -7.91x | -34.82x | -30.16x | -14.44x | -23.84x | -18.44x |
| Total Equity | 243.06M | 350.23M | 115.18M | -51.59M | -223.84M | -303.75M | -338.57M | 441.8M | 213M | 175.54M |
| Equity Growth % | -16.12% | 44.09% | -67.11% | -144.79% | -333.89% | -35.7% | -11.46% | 230.49% | -51.79% | -17.58% |
| Book Value per Share | 7.12 | 7.83 | 2.20 | -0.96 | -4.03 | -4.87 | -4.87 | 6.00 | 3.85 | 3.59 |
| Total Shareholders' Equity | 243.06M | 350.23M | 115.18M | -51.59M | -223.84M | -303.75M | -338.57M | 441.8M | 213M | 175.54M |
| Common Stock | 0 | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 0 | 0 |
| Retained Earnings | -321.56M | -512.23M | -797.74M | -1.01B | -1.25B | -1.53B | -1.73B | -853.91M | -909.1M | -965.52M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -70K | -253K | -733K | -166K | 145K | 47K | 0 | -15K | -65K | 7K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -168.86M | -98.99M | -201.05M | -112.87M | -238.2M | -250.4M | -207.86M | -186.99M | -27M | -11.54M |
| Operating CF Margin % | -400.84% | -203.48% | -1306.72% | -186.96% | -324.46% | -348.47% | -375.8% | -364.18% | -47.01% | -17.92% |
| Operating CF Growth % | 3.6% | 41.38% | -103.11% | 43.86% | -111.04% | -5.12% | 16.99% | 10.04% | 85.56% | 57.27% |
| Net Income | -182.22M | -190.67M | -285.4M | -215.52M | -236.46M | -294.82M | -265.07M | -92.82M | -55.19M | -56.42M |
| Depreciation & Amortization | 2.99M | 3.12M | 4.03M | 3.17M | 6.21M | 6.97M | 8.6M | 7.02M | 4.26M | 3.62M |
| Stock-Based Compensation | 54.05M | 41.17M | 49.15M | 51.31M | 60.45M | 62.98M | 62.06M | 39.73M | 25.37M | 21.39M |
| Deferred Taxes | 2.17M | 282K | 8.74M | -11.21M | 0 | 0 | 0 | 0 | 3.21M | -7.57M |
| Other Non-Cash Items | -8.06M | 182K | 10K | -43K | -23.01M | 12.25M | 26.1M | -183.28M | 3.7M | 7.09M |
| Working Capital Changes | -37.78M | 46.93M | 22.43M | 59.43M | -45.4M | -37.78M | -39.55M | 42.35M | -8.34M | 20.36M |
| Change in Receivables | -1.63M | 1.28M | -1.61M | 1.63M | -15.02M | 6.13M | 1.8M | -2.72M | 0 | -966K |
| Change in Inventory | 1.03M | -3.18M | -7.3M | -1.63M | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 8.72M | -16.44M | 3.8M | 3.58M | -4.27M | 3.66M | -3.53M | -1.61M | 6K | 750K |
| Cash from Investing | 111.04M | -148.24M | -56.33M | 176.71M | -83.05M | 10.72M | 124.49M | 1.15B | -32.7M | 12.28M |
| Capital Expenditures | -2.65M | -2.13M | -2.41M | -7.24M | -3.18M | -6.62M | -3.41M | -572K | -2.49M | -332K |
| CapEx % of Revenue | 6.28% | 4.39% | 15.64% | 11.99% | 4.33% | 9.21% | 6.16% | 1.11% | 4.33% | 0.52% |
| Acquisitions | 0 | 0 | 0 | 20M | 5M | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 113.69M | -146.1M | -53.93M | 17K | 5K | 64K | 6K | 1.1B | 1.51M | 0 |
| Cash from Financing | 81.31M | 479.23M | 1.66M | 225.2M | 1.29M | 263.08M | 91.86M | -758.81M | -198.93M | -2.5M |
| Debt Issued (Net) | 0 | 222.5M | 0 | 229.44M | -2.15M | 144.65M | -10.73M | -631.6M | 0 | 0 |
| Equity Issued (Net) | 1000K | 1000K | -1000K | -1000K | -1000K | 1000K | 1000K | -1000K | -1000K | -1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -756K | -3.87M | -8.56M | -9.81M | -3.17M | -9.75M | -9.06M | -132.28M | -199.55M | -3.1M |
| Other Financing | 3.05M | 7.57M | 10.22M | 5.57M | 6.62M | -11.73M | 3.47M | 5.08M | 618K | 508K |
| Net Change in Cash | 23.49M | 232M | -255.73M | 289.04M | -319.96M | 23.4M | 8.5M | 208.21M | -258.63M | -1.75M |
| Free Cash Flow | -171.5M | -101.12M | -203.46M | -120.11M | -241.37M | -257.02M | -211.26M | -187.56M | -29.48M | -11.87M |
| FCF Margin % | -407.12% | -207.87% | -1322.36% | -198.95% | -328.78% | -357.68% | -381.96% | -365.29% | -51.35% | -18.43% |
| FCF Growth % | 3.79% | 41.04% | -101.2% | 40.97% | -100.96% | -6.48% | 17.8% | 11.22% | 84.28% | 59.75% |
| FCF per Share | -5.02 | -2.26 | -3.89 | -2.23 | -4.34 | -4.12 | -3.04 | -2.55 | -0.53 | -0.24 |
| FCF Conversion (FCF/Net Income) | 0.93x | 0.52x | 0.70x | 0.52x | 1.01x | 0.90x | 1.04x | -0.21x | 0.49x | 0.20x |
| Interest Paid | 0 | 0 | 7.45M | 7.47M | 26.18M | 24.02M | 39.03M | 22.24M | 0 | 0 |
| Taxes Paid | 13.39M | 9.49M | 4.93M | -7.32M | 22K | 14K | 0 | 117.97M | 24K | 109K |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -68.39% | -64.27% | -122.65% | -677.87% | - | - | - | 1689.74% | -16.86% | -29.04% |
| Return on Invested Capital (ROIC) | -82.45% | -75.5% | -81.6% | -130.38% | -149.14% | -85.91% | -72.68% | -31.58% | -20.09% | -17.17% |
| Gross Margin | 88.95% | 94.05% | 60.81% | 98.82% | 100% | 100% | -250.12% | -23.46% | 29.26% | 100% |
| Net Margin | -432.56% | -391.94% | -1854.97% | -357.01% | -322.08% | -386.9% | -360.55% | 1698.54% | -96.11% | -87.63% |
| Debt / Equity | - | 0.64x | 1.94x | - | - | - | - | 0.12x | 0.23x | 0.28x |
| Interest Coverage | - | -128.54x | -30.43x | -22.78x | -7.91x | -34.82x | -30.16x | -14.44x | -23.84x | -18.44x |
| FCF Conversion | 0.93x | 0.52x | 0.70x | 0.52x | 1.01x | 0.90x | 1.04x | -0.21x | 0.49x | 0.20x |
| Revenue Growth | 260.42% | 15.48% | -68.37% | 292.37% | 21.61% | -2.12% | -23.03% | -7.17% | 11.84% | 12.12% |
Explore detailed financial history, valuation models, and returns analysis
DCF models, peer multiples & analyst estimates
Historical returns with dividends reinvested
Yield, growth, payout safety & DRIP calculator
EPS trends, net income & profitability analysis
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of valuation, profitability & efficiency metrics